Impact of interpreters on the receipt of new prescription medication information among Spanish-speaking Latinos.
BACKGROUND
For Latinos, limited English proficiency (LEP) is a barrier to receiving important information about a new medication prescription. Access to interpreters may impact the receipt of important medication-related information.


OBJECTIVE
To examine the association between interpreter use and reports of new prescription medication advice among Latinos with LEP.


METHODS
We examined cross-sectional survey data from 1590 Latino adults with LEP from 8 sites across the United States. The main outcomes are 5 measures of new prescription medication advising: (1) explanation of medication purpose, (2) explanation of possible side effects, (3) explanation of medication directions, (4) receipt of written information in Spanish from pharmacy, and (5) receipt of medicine bottle with Spanish language label.


RESULTS
Among patients prescribed a new medication, 72% reported being told about the purpose of the medication, 52% about possible side effects, and 70% about how to take the new medicine. Forty-four percent said they received written medication information in Spanish from pharmacy, and 47% said their medicine bottle label was written in Spanish. Interpreter use was independently associated with receiving explanations about: possible side effects (adjusted odds ratio [AOR] = 1.81; 95% confidence intervals [CI]: 1.16-2.45); medication directions (AOR = 2.50; 95% CI: 1.67-3.59); and medication purpose (AOR = 3.55; 95% CI: 2.14-4.65).


CONCLUSIONS
Among Latinos with LEP, interpreter use increases patient receipt of important information when a new medication is prescribed. There is a continuing need for effective policies and interventions to improve provider communication with LEP patients.
Robert Wood Johnson Clinical Scholars Program, University of California Los Angeles, Los Angeles, CA 90095, USA. gmoreno@ucla.edu
Gerardo
G
Moreno
Derjung M
DM
Tarn
Leo S
LS
Morales
D000293:Adolescent; D000328:Adult; D003430:Cross-Sectional Studies; D004348:Drug Labeling / Q000379:methods*; D005260:Female; D006304:Health Status; D006630:Hispanic or Latino; D006801:Humans; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic / Q000379:methods; D055553:Prescription Drugs; D012959:Socioeconomic Factors; D014175:Translating; D014481:United States; D055815:Young Adult
D055553:Prescription Drugs